Ketogenic metabolic therapy as a candidate adjunct for CBTp delivery in schizophrenia spectrum disorders

cbtpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This perspective article proposes ketogenic metabolic therapy (KMT) as a potential adjunct to cognitive-behavioral therapy for psychosis (CBTp) to address participation barriers such as sleep disruption, cognitive burden, and mood instability in schizophrenia spectrum disorders. The author outlines a care pathway model to evaluate whether KMT can improve CBTp initiation, retention, and completion by mitigating these limiting factors. The resource is intended for clinical psychologists interested in engagement frameworks and measurable indicators for adjunctive interventions.

ID
0d41e68d43cf4316
Source org
PubMed Central
Author
Nicole Laurent (Renewable Energy Systems (United States))
Published
2026-03-25
OA status
gold
DOI
10.3389/fpsyg.2026.1775511
PMID
Not recorded
PMCID
Not recorded
Citations
0

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:0d41e68d43cf4316,
  title = {Ketogenic metabolic therapy as a candidate adjunct for CBTp delivery in schizophrenia spectrum disorders},
  author = {Nicole Laurent},
  year = {2026},
  journal = {PubMed Central},
  doi = {10.3389/fpsyg.2026.1775511},
  url = {https://doi.org/10.3389/fpsyg.2026.1775511}
}

RIS

TY  - JOUR
TI  - Ketogenic metabolic therapy as a candidate adjunct for CBTp delivery in schizophrenia spectrum disorders
AU  - Laurent, Nicole
PY  - 2026
PB  - PubMed Central
DO  - 10.3389/fpsyg.2026.1775511
UR  - https://doi.org/10.3389/fpsyg.2026.1775511
ER  -

APA

Laurent, N. (2026). Ketogenic metabolic therapy as a candidate adjunct for CBTp delivery in schizophrenia spectrum disorders. PubMed Central. https://doi.org/10.3389/fpsyg.2026.1775511

Related entries

More like this